CHI3L1 encodes for YKL-40, which is a secreted protein that has been reported to be overexpressed in a number of different cancers, including glioma, and has been proposed as a new therapeutic target (Pelloski et al, 2005; Johansen et al, 2007). Here, CHI3L1 is linked to central nervous system cancer.